Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer: A study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres

Định dạng: pdf / Số trang: 10

Nhắn tin với admin nếu không tải được